Skip to main content
ES
v1.2
Log in
G

Glaxosmi Pharma

GLAXOSMI PHARMANSE
₹2,536+0.00 (+0.00%)
Market Cap
₹43,531Cr.
P/E Ratio
41.3
P/B Ratio
18.93
EPS (TTM)
₹61.40
Div Yield
2.25%
ROCE
61.4%
ROE
45.6%
52W Low: ₹2,08852W High: ₹3,121
Themes:💊 Pharma & CDMO
Appears in 2 screens
🏆Quality Compounders
100
🛡️Low-Volatility Defensives
58
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 6.0% a year over three years.
  • Debt is 0.01× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Glaxosmi_Pharma — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5.5/ 10Overall
3/ 10Valuation
9/ 10Quality
5/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 41.3P/E: 41.3 | P/B: 18.93
Growth
ModestSales CAGR — 3Y: 6% · 1Y: 6%
Profitability
High MarginROCE: 61.4% | ROE: 45.6%

Key Metrics

Valuation
PEG Ratio 2.29
Price / Sales 11.01x
Price / FCF 50.0x
Book Value ₹134
Margins & returns
Operating Margin 34%
Net Margin 27.0%
Return on Assets 24.7%

Frequently Asked Questions

MarketsPortfolioChart